Downregulation of LAPTM4B Contributes to the Impairment of the Autophagic Flux via Unopposed Activation of mTORC1 Signaling During Myocardial Ischemia/Reperfusion Injury.

Circulation Research
Shanshan GuHuang-Tian Yang

Abstract

Impaired autophagic flux contributes to ischemia/reperfusion (I/R)-induced cardiomyocyte death, but the underlying molecular mechanisms remain largely unexplored. To determine the role of LAPTM4B (lysosomal-associated transmembrane protein 4B) in the regulation of autophagic flux and myocardial I/R injury. LAPTM4B was expressed in murine hearts but downregulated in hearts with I/R (30 minutes/2 hours) injury and neonatal rat cardiomyocytes with hypoxia/reoxygenation (6 hours/2 hours) injury. During myocardial reperfusion, LAPTM4B-knockout (LAPTM4B-/-) mice had a significantly increased infarct size and lactate dehydrogenase release, whereas adenovirus-mediated LAPTM4B-overexpression was cardioprotective. Concomitantly, LAPTM4B-/- mice showed higher accumulation of the autophagy markers LC3-II (microtubule-associated protein 1A/1B-light chain 3), but not P62, in the I/R heart, whereas they did not alter chloroquine-induced further increases of LC3-II and P62 in both sham and I/R hearts. Conversely, LAPTM4B-overexpression had opposite effects. The hypoxia/reoxygenation-reduced viability of neonatal rat cardiomyocytes, ratio of autolysosomes/autophagosomes, and function of lysosomes were further decreased by LAPTM4B-knockdown but ...Continue Reading

References

Sep 11, 2002·Molecular Biology of the Cell·Eeva-Liisa EskelinenPaul Saftig
May 4, 2004·Molecular Biology of the Cell·Eeva-Liisa EskelinenPaul Saftig
Oct 10, 2006·The Journal of Biological Chemistry·Melaine DelcroixJames H McKerrow
Sep 15, 2007·The New England Journal of Medicine·Derek M Yellon, Derek J Hausenloy
Feb 22, 2008·Methods in Molecular Medicine·Ronglih Liao, Mohit Jain
May 24, 2008·Science·Yasemin SancakDavid M Sabatini
Dec 26, 2009·Current Opinion in Cell Biology·Zhifen Yang, Daniel J Klionsky
Jul 9, 2011·Circulation Research·Peiyong ZhaiJunichi Sadoshima
Sep 25, 2012·Journal of Molecular and Cellular Cardiology·Anindita DasRakesh C Kukreja
Jan 15, 2015·Annual Review of Medicine·Giancarlo ParentiAndrea Ballabio
Jan 17, 2015·Cell·Xiaojun TanRichard A Anderson
May 23, 2015·Nature Communications·Ruth MilkereitDaniela Rotin
Apr 15, 2017·The Biochemical Journal·Bernadette Carroll, Elaine A Dunlop
Oct 11, 2017·Journal of Molecular and Cellular Cardiology·Bo PanXuejun Wang
Oct 27, 2017·Annual Review of Physiology·Sebastiano SciarrettaJunichi Sadoshima
Feb 9, 2018·Circulation Research·Sebastiano SciarrettaJunichi Sadoshima
Aug 21, 2018·Traffic·Fengjuan WangPatricia Boya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.